CCDC114 Protein
Overview
CCDC114 (Coiled-Coil Domain-Containing Protein 114) is a conserved protein characterized by the presence of coiled-coil structural domains, which are regions of protein structure formed by two or more alpha-helices wound around each other. The CCDC114 gene is located on chromosome 2q37.1 in humans and encodes a protein of approximately 115 kilodaltons. As a member of the broader family of coiled-coil domain-containing proteins, CCDC114 shares structural features with other proteins involved in cellular organization, intracellular trafficking, and cytoskeletal regulation. The protein has emerged as a focus of neurodegeneration research due to its involvement in cellular pathways disrupted in neurodegenerative diseases, particularly through its association with axonal transport and mitochondrial dynamics.
Function/Biology
CCDC114 functions primarily as a structural and regulatory protein involved in axonal organization and intracellular transport machinery. The coiled-coil domains enable CCDC114 to mediate protein-protein interactions, serving as a scaffolding component that facilitates the assembly and function of multi-protein complexes. Within neurons, CCDC114 has been implicated in the organization of the axoneme—the core structure of cilia and flagella—and in regulating dynein-based motor complex function. The protein localizes to microtubule-associated structures and participates in the regulation of transport vesicles and organelles along neuronal microtubules.
...CCDC114 Protein
Overview
CCDC114 (Coiled-Coil Domain-Containing Protein 114) is a conserved protein characterized by the presence of coiled-coil structural domains, which are regions of protein structure formed by two or more alpha-helices wound around each other. The CCDC114 gene is located on chromosome 2q37.1 in humans and encodes a protein of approximately 115 kilodaltons. As a member of the broader family of coiled-coil domain-containing proteins, CCDC114 shares structural features with other proteins involved in cellular organization, intracellular trafficking, and cytoskeletal regulation. The protein has emerged as a focus of neurodegeneration research due to its involvement in cellular pathways disrupted in neurodegenerative diseases, particularly through its association with axonal transport and mitochondrial dynamics.
Function/Biology
CCDC114 functions primarily as a structural and regulatory protein involved in axonal organization and intracellular transport machinery. The coiled-coil domains enable CCDC114 to mediate protein-protein interactions, serving as a scaffolding component that facilitates the assembly and function of multi-protein complexes. Within neurons, CCDC114 has been implicated in the organization of the axoneme—the core structure of cilia and flagella—and in regulating dynein-based motor complex function. The protein localizes to microtubule-associated structures and participates in the regulation of transport vesicles and organelles along neuronal microtubules.
CCDC114 expression is particularly prominent in neurons and tissues with high metabolic demands, suggesting roles in maintaining cellular homeostasis and energy metabolism. The protein interacts with dynein and dynactin complexes, which are responsible for retrograde axonal transport—the movement of cargo from axon terminals back toward the neuronal soma. This retrograde transport system is essential for the delivery of neurotrophic signals, recycling of membrane components, and removal of misfolded proteins and damaged organelles.
Role in Neurodegeneration
CCDC114 dysfunction has been linked to multiple neurodegenerative pathways through its involvement in axonal transport defects and mitochondrial dysfunction. Impaired retrograde axonal transport prevents the efficient delivery of critical survival signals to neuronal cell bodies and disrupts the removal of toxic proteins and damaged mitochondria from distal axons. This process becomes particularly critical during aging and in disease states where protein misfolding and oxidative stress accumulate.
In Alzheimer's disease pathology, altered axonal transport contributes to amyloid-beta and tau accumulation in vulnerable neurons. CCDC114 alterations may compromise the clearance of these pathogenic proteins from axons, exacerbating neurodegeneration. Similarly, in Parkinson's disease, defective transport mechanisms impair the degradation of alpha-synuclein aggregates and compromise mitochondrial quality control in dopaminergic neurons. CCDC114 dysregulation has also been investigated in the context of amyotrophic lateral sclerosis (ALS), where motor neuron degeneration is partly driven by impaired axonal transport and accumulation of protein aggregates, particularly TDP-43 and SOD1.
Molecular Mechanisms
At the molecular level, CCDC114 exerts its effects through direct and indirect interactions with motor protein complexes. The protein associates with components of the dynein-dynactin complex, which generates the force for retrograde transport along microtubules. CCDC114's coiled-coil domains facilitate the formation of higher-order protein assemblies necessary for productive motor complex activity. Post-translational modifications of CCDC114, including phosphorylation and ubiquitination, regulate its interaction partners and cellular localization.
CCDC114 also participates in mitochondrial dynamics through its role in mediating the transport and positioning of mitochondria along microtubules. By regulating mitochondrial distribution, CCDC114 influences local energy production and calcium buffering capacity in axons, processes that are essential for maintaining synaptic function. Dysregulation of CCDC114 may impair mitochondrial fission-fusion balance or prevent proper mitochondrial removal through autophagy, leading to accumulated dysfunctional mitochondria.
Clinical/Research Significance
CCDC114 represents a potential biomarker and therapeutic target for neurodegenerative diseases characterized by axonal transport defects. Research into CCDC114 function has revealed new insights into how transport system failures contribute to neurodegeneration. Genetic variations in CCDC114 may influence disease susceptibility or progression, though large-scale genome-wide association studies are needed to fully characterize these associations.
Therapeutic approaches targeting CCDC114 or its interacting partners could restore axonal transport capacity and enhance neuronal survival in degenerative conditions.
- Dynein and dynactin complexes
- Retrograde axonal transport
- Mitochondrial dynamics and quality control
- Tau and amyloid-beta pathology
- Alpha-synuclein aggregation
- TDP-43 and protein aggregation pathways
- Axoneme organization
- Neuroinflammation and neurodegeneration